SUESS MICROTEC SE NA O.N./ DE000A1K0235 /
2024-06-03 1:45:20 PM | Chg. -1.60 | Volume | Bid2:07:35 PM | Ask2:06:51 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
53.00EUR | -2.93% | 38,612 Turnover: 2.07 mill. |
53.00Bid Size: 897 | 53.20Ask Size: 169 | 1.02 bill.EUR | 0.38% | 58.46 |
GlobeNewswire
2:20 PM
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
GlobeNewswire
2:15 PM
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-I...
GlobeNewswire
2:14 PM
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire
2:10 PM
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution ...
GlobeNewswire
2:07 PM
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental W...
GlobeNewswire
2:05 PM
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at...
GlobeNewswire
2:04 PM
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
GlobeNewswire
2:02 PM
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
GlobeNewswire
2:01 PM
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
GlobeNewswire
2:00 PM
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Tre...
GlobeNewswire
2:00 PM
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
GlobeNewswire
2:00 PM
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome T...